AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 47 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $3,317,000 | -48.3% | 285,000 | -28.8% | 0.08% | -54.7% |
| Q2 2020 | $6,412,000 | +114.1% | 400,000 | -20.0% | 0.18% | +40.9% |
| Q1 2020 | $2,995,000 | -54.6% | 500,000 | 0.0% | 0.13% | -50.2% |
| Q4 2019 | $6,600,000 | +6.3% | 500,000 | 0.0% | 0.26% | +2.4% |
| Q3 2019 | $6,210,000 | -22.9% | 500,000 | 0.0% | 0.25% | -23.6% |
| Q2 2019 | $8,050,000 | -43.2% | 500,000 | +11.1% | 0.33% | -43.6% |
| Q1 2019 | $14,162,000 | -9.2% | 450,000 | -5.3% | 0.58% | 0.0% |
| Q4 2018 | $15,599,000 | +1.7% | 475,000 | -5.0% | 0.58% | +44.9% |
| Q3 2018 | $15,335,000 | +9.0% | 500,000 | -4.8% | 0.40% | +33.4% |
| Q2 2018 | $14,065,000 | – | 525,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 21,346,829 | $49,738,112 | 74.10% |
| TFG Asset Management GP Ltd | 12,000,000 | $27,960,000 | 5.10% |
| Paradigm Biocapital Advisors LP | 14,406,782 | $33,567,802 | 2.28% |
| Lynx1 Capital Management LP | 1,363,025 | $3,175,848 | 2.10% |
| Deep Track Capital, LP | 15,000,000 | $34,950,000 | 1.35% |
| Affinity Asset Advisors, LLC | 1,992,466 | $4,642,446 | 1.31% |
| DAFNA Capital Management LLC | 928,253 | $2,162,829 | 0.67% |
| Frazier Life Sciences Management, L.P. | 3,746,857 | $8,730,177 | 0.58% |
| ARMISTICE CAPITAL, LLC | 6,900,000 | $16,077,000 | 0.25% |
| Blackstone Inc. | 20,485,611 | $47,731,474 | 0.20% |